Frequently Asked Questions
The market is segmented based on Segmentation, By Type (MEL, COS, CHO, Insect cells, Reagents, Expression Vectors, and Competent Cells), Host Type (S.Cerevisiae, Filamentous Fungi, Leishamania, and Baculovirus Infected Cells), Application (Bacterial Expression System, Yeast Expression System, Insect Expression System, and Mammalian Expression System) – Industry Trends and Forecast to 2031
.
The Global Eukaryotic Expression Systems Market size was valued at USD 724.57 USD Million in 2023.
The Global Eukaryotic Expression Systems Market is projected to grow at a CAGR of 5.5% during the forecast period of 2024 to 2031.
The major players operating in the market include AGilent TechnologiesInc. ,Merck KGaA ,Bio-Rad LaboratoriesInc. ,QIAGEN ,Promega Corporation ,Thermo Fischer ScientificInc. ,Takara Bio Inc. ,GenScript ,New England Biolabs ,Oxford Expression Technologies Ltd ,LifeSensors Inc. ,Lonza ,proteogenixx ,Sygnature Discovery ,Sino Biological Inc. ,ARTES Biotechnology GmbH .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
